Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Strides Shasun Q2 net...

    Strides Shasun Q2 net profit rises over two-fold to Rs 74cr

    Written by savita thakur thakur Published On 2016-10-31T09:14:17+05:30  |  Updated On 31 Oct 2016 9:14 AM IST
    Strides Shasun Q2 net profit rises over two-fold to Rs 74cr

    New Delhi : Drug firm Strides Shasun reported over two-fold jump in consolidated net profit to Rs 74.09 crore during the second quarter ended September 30, on account of higher sales.


    The company had posted a net profit of Rs 35.81 crore for the corresponding period of previous fiscal.


    The company's total income from operations went up by 33.34 per cent to Rs 953.47 crore during the quarter under review compared to Rs 715.06 crore in the year-ago period, Strides Shasun said in a BSE filing.


    "The regulated markets and the institutional business continue to deliver healthy growth with an improved sequential performance on a higher revenue base Active pharmaceutical ingredients (API) performance during the quarter was impacted," Strides Shasun Executive Vice Chairman and Managing Director Arun Kumar said.


    Shares of Strides Shasun were trading 8.19 per cent higher at Rs 1,016.77 on BSE.

    Active Pharmaceutical IngredientAPIMD Arun KumarStrides Shasun
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok